Biocompatibility Testing Services

Biocompatibility testing establishes whether a material or device produces an adverse biological response in contact with tissue. The requirement is not a fixed list of assays. It is determined by the nature and duration of body contact, and a study program assembled without reference to that classification will either omit required elements or perform tests the application does not call for.

Altogen Labs conducts biocompatibility studies selected according to material composition, contact type, contact duration, and the applicable requirements for the intended application. To discuss which evaluations a specific material requires, request a quote.

Contact classification drives the program

The relevant variables are the tissue the material contacts, whether contact is with intact surface, breached surface, blood, or implanted tissue, and whether it is limited, prolonged, or permanent. A short-contact surface material and a permanently implanted device sit at opposite ends of that range and require substantially different evaluation.

Establishing the classification first, and selecting studies against it, produces a defensible program. Beginning with a list of available assays and working backward produces one that is difficult to justify to a reviewer.

Evaluations

Study selection may include cytotoxicity evaluation in cell culture, irritation and sensitization assessment, acute and repeat-dose systemic toxicity, implantation studies with local tissue response assessment, and hemocompatibility evaluation for blood-contacting materials. Sample preparation, including extraction conditions where the test article is assessed as an extract rather than directly, is defined per material, since extraction vehicle and conditions materially affect the result and are frequently the point at which a study is questioned.

Histopathological evaluation of local tissue response is central to implantation studies, with findings graded against a defined scale and compared against a control material rather than described narratively.

Applied examples

Extract cytotoxicity. A polymer is extracted under defined conditions and the extract assessed against cultured cells for cytotoxic effect, with extraction vehicle and duration stated as part of the result rather than treated as incidental.

Implantation response. A material is implanted with a control material in the same animal, with local tissue response assessed histologically at defined intervals and graded against the control rather than against an absolute standard.

Repeat-dose systemic assessment. An extract is administered repeatedly with body weight, clinical observations, clinical pathology, and organ histopathology assessed, establishing whether systemic effects accompany the local response.

Scope of claims

Study design is selected according to the material, contact type, duration, and applicable requirements for the intended application. Altogen Labs does not represent that all device categories are covered, nor that every element of any single standard is performed in house, and will state plainly which elements of a required program fall outside its scope so that a sponsor can plan for them rather than discover the gap during review.

Conduct and reporting

Test article preparation, extraction conditions where applicable, control materials, observation schedule, grading criteria, and acceptance criteria are defined before initiation. Reports state the classification assumed, the studies performed, the methods used, and per-animal or per-replicate results alongside summary conclusions. All in vivo procedures are conducted under active IACUC protocols. GLP standards are applied where a study is formally designated as GLP.

Send material composition, intended contact type and duration, and the regulatory context, or request a quote.